BioSig Technologies [BSGM] vs Boston Scientific [BSX] Detailed Stock Comparison

BioSig Technologies

NASDAQ

Boston Scientific

NYSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: BioSig Technologies wins in 5 metrics, Boston Scientific wins in 10 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	BioSig Technologies	Boston Scientific	Better
P/E Ratio (TTM)	N/A	61.76	N/A
Price-to-Book Ratio	36.51	6.85	Boston Scientific
Debt-to-Equity Ratio	0.01	53.09	BioSig Technologies
PEG Ratio	-6.54	0.42	BioSig Technologies
EV/EBITDA	-5.72	34.95	BioSig Technologies
Profit Margin (TTM)	0.00%	13.55%	Boston Scientific
Operating Margin (TTM)	-211,407.70%	18.63%	Boston Scientific
EBITDA Margin (TTM)	N/A	18.63%	N/A
Return on Equity	739.31%	11.55%	BioSig Technologies
Return on Assets (TTM)	-30.45%	5.39%	Boston Scientific
Free Cash Flow (TTM)	$-4.76M	$2.37B	Boston Scientific
1-Year Return	1,060.47%	32.89%	BioSig Technologies
Price-to-Sales Ratio (TTM)	11,976.44	8.31	Boston Scientific
Enterprise Value	$153.48M	$164.42B	Boston Scientific
EV/Revenue Ratio	11,806.49	8.89	Boston Scientific
Gross Profit Margin (TTM)	N/A	67.65%	N/A
Revenue per Share (TTM)	$0	$13	Boston Scientific
Earnings per Share (Diluted)	$-0.53	$1.68	Boston Scientific
Beta (Stock Volatility)	N/A	0.66	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

BioSig Technologies vs Boston Scientific Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
BioSig Technologies	5.72%	-2.16%	-13.37%	51.21%	436.56%	256.43%
Boston Scientific	-0.79%	1.02%	1.38%	0.54%	0.69%	17.71%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
BioSig Technologies	1,060.47%	-53.80%	-93.34%	-86.78%	-94.30%	-94.30%
Boston Scientific	32.89%	159.65%	156.42%	516.34%	1,816.39%	301.11%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

BioSig Technologies (BSGM): View Full Stock Overview

Boston Scientific (BSX): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: BioSig Technologies vs Boston Scientific

Metric	BSGM	BSX
Market Information
Market Cap i	$155.69M	$153.73B
Market Cap Category	Micro cap	Large cap
10 Day Avg. Volume i	829,590	6,087,580
90 Day Avg. Volume i	1,352,030	7,069,760
Last Close	$4.99	$105.21
52 Week Range	$0.23 - $14.11	$78.30 - $108.94
% from 52W High	-64.64%	-3.42%
All-Time High	$124.30 (May 11, 2020)	$108.94 (Jul 23, 2025)
% from All-Time High	-95.99%	-3.42%
Growth Metrics
Quarterly Revenue Growth	-1.00%	0.23%
Quarterly Earnings Growth	-1.00%	1.46%
Financial Health
Profit Margin (TTM) i	0.00%	0.14%
Operating Margin (TTM) i	-2,114.08%	0.19%
Return on Equity (TTM) i	7.39%	0.12%
Debt to Equity (MRQ) i	0.01	53.09
Cash & Liquidity
Book Value per Share (MRQ)	$-0.12	$15.14
Cash per Share (MRQ)	$0.09	$0.36
Operating Cash Flow (TTM) i	$-4,356,000	$4.28B
Levered Free Cash Flow (TTM) i	$101.23M	$2.94B
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: BioSig Technologies vs Boston Scientific

Metric	BSGM	BSX
Price Ratios
P/E Ratio (TTM) i	N/A	61.76
Forward P/E i	-6.54	37.19
PEG Ratio i	-6.54	0.42
Price to Sales (TTM) i	11,976.44	8.31
Price to Book (MRQ) i	36.51	6.85
Market Capitalization
Market Capitalization i	$155.69M	$153.73B
Enterprise Value i	$153.48M	$164.42B
Enterprise Value Metrics
Enterprise to Revenue i	11,806.49	8.89
Enterprise to EBITDA i	-5.72	34.95
Risk & Other Metrics
Beta i	N/A	0.66
Book Value per Share (MRQ) i	$-0.12	$15.14

Financial Statements Comparison: BioSig Technologies vs Boston Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BSGM	BSX
Revenue/Sales i	$0	$4.66B
Cost of Goods Sold i	N/A	$1.45B
Gross Profit i	N/A	$3.21B
Research & Development i	$19,000	$443.00M
Operating Income (EBIT) i	$-20.37M	$937.00M
EBITDA i	$-19.81M	$1.23B
Pre-Tax Income i	$-20.37M	$805.00M
Income Tax i	$0	$133.00M
Net Income (Profit) i	$-20.37M	$672.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BSGM	BSX
Cash & Equivalents i	$3.73M	$725.00M
Total Current Assets i	$3.99M	$7.34B
Total Current Liabilities i	$1.68M	$5.06B
Long-Term Debt i	N/A	$10.93B
Total Shareholders Equity i	$2.74M	$22.45B
Retained Earnings i	$-258.16M	$3.35B
Property, Plant & Equipment i	$814,000	$448.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BSGM	BSX
Operating Cash Flow i	$-490,000	$513.00M
Capital Expenditures i	N/A	$-187.00M
Free Cash Flow i	$-1.12M	$277.00M
Debt Repayment i	N/A	$-1.31B
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	BSGM	BSX
Shares Short i	1.35M	16.27M
Short Ratio i	0.90	2.15
Short % of Float i	0.05%	0.01%
Average Daily Volume (10 Day) i	829,590	6,087,580
Average Daily Volume (90 Day) i	1,352,030	7,069,760
Shares Outstanding i	17.24M	1.47B
Float Shares i	24.64M	1.48B
% Held by Insiders i	0.29%	0.00%
% Held by Institutions i	0.29%	0.94%

Dividend Analysis & Yield Comparison: BioSig Technologies vs Boston Scientific

Metric	BSGM	BSX
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

BioSig Technologies [BSGM] vs Boston Scientific [BSX] Detailed Stock Comparison